ArticlePatient preference and adherence2018
"I did not want to take that medicine": African-Americans' reasons for diabetes medication nonadherence and perceived solutions for enhancing adherence.
Article in Patient preference and adherence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.
- Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.British journal of clinical pharmacology · 2025Pooled it
- Understanding the influence of ethnicity on adherence to antidiabetic medication: Meta-ethnography and systematic review.PloS one · 2023Pooled it
- Pooled it
- A pilot mixed methods randomized control trial investigating the feasibility and acceptability of a culturally tailored intervention focused on beliefs, mistrust and race-congruent peer support for Black adults with diabetes.Frontiers in public health · 2025Trial
- Texas strength through resilience in diabetes education (TX STRIDE): Protocol for a non-randomized cluster-controlled trial among African American adults with type 2 diabetes.Contemporary clinical trials · 2026Article
- Exploring Perceived Discrimination and Medical Mistrust among Middle-Aged Black Adults.Journal of racial and ethnic health disparities · 2026Article
- "We Don't Get Drugs Targeted for Us:" Applying the Integrated Behavioral Model to Understand Why Black Women Chose to Participate in a Breast Cancer Clinical Trial.Health communication · 2025Article
- Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.British journal of clinical pharmacology · 2025Review
- Optimizing diabetes management interventions for Black and Hispanic adults using the multiphase optimization strategy: Protocol for a randomized mixed methods factorial trial.Contemporary clinical trials · 2025Article
- A network analysis to explore illness perceptions in Black adults with type 2 diabetes.British journal of health psychology · 2025Article
- Peer education strategies validated through Delphi at an urban university in KwaZulu-Natal.Health SA = SA Gesondheid · 2025Article
- Investigating the Added Value of a Culturally Tailored Peer Support Intervention for Black Adults with Diabetes: A Randomized Mixed Methods Pilot Trial.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- Medication Adherence in American Indians With Type 2 Diabetes: An Integrative Review.Diabetes spectrum : a publication of the American Diabetes Association · 2023Article
- Continuity of Medication Use by US Adults With Diabetes, 2005-2019.JAMA network open · 2023Article
- Pain, No Gain?: A Narrative Analysis Exploring the Accounts of Older African American Patients and Their Discussion of Pain Management Related to Chronic Illness.Rhetoric of health & medicine · 2023Article
- Protocol for a Pilot Randomized Controlled Mixed Methods Feasibility Trial of a Culturally Adapted Peer Support and Self-Management Intervention for African Americans.Pharmacy (Basel, Switzerland) · 2022Article
- A feasibility pilot trial of a peer-support educational behavioral intervention to improve diabetes medication adherence in African Americans.Pilot and feasibility studies · 2022Article
- Perspectives on a Novel Culturally Tailored Diabetes Self-Management Program for African Americans: A Qualitative Study of Healthcare Professionals and Organizational Leaders.International journal of environmental research and public health · 2022Article
- Racial and Ethnic Disparities in Healthcare Rating, Diabetes Self-efficacy, and Diabetes Management Among Non-pregnant Women of Childbearing Age: Does Socioeconomic Status Matter?Journal of racial and ethnic health disparities · 2022Article
- Psychometric evaluation of a culturally adapted illness perception questionnaire for African Americans with type 2 diabetes.BMC public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundDiabetes is disproportionally burdensome among African-Americans (AAs) and medication adherence is important for optimal outcomes. Limited studies have qualitatively examined reasons for nonadherence among AAs with type 2 diabetes, though AAs are less adherent to prescribed medications compared to whites. This study explored the reasons for medication nonadherence and adherence among AAs with type 2 diabetes and examined AAs' perceived solutions for enhancing adherence.
methodsForty AAs, age 45-60 years with type 2 diabetes for at least 1 year prior, taking at least one prescribed diabetes medication, participated in six semistructured 90-minute focus groups. Using a phenomenology qualitative approach, reasons for nonadherence and adherence, as well as participants' perceived solutions for increasing adherence were explored. Qualitative content analysis was conducted.
resultsAAs' reasons for intentional nonadherence were associated with 1) their perception of medicines including concerns about medication side effects, as well as fear and frustration associated with taking medicines; 2) their perception of illness (disbelief of diabetes diagnosis); and 3) access to medicines and information resources. Participants reported taking their medicines because they valued being alive to perform their social and family roles, and their belief in the doctor's recommendation and medication helpfulness. Participants provided solutions for enhancing adherence by focusing on the roles of health care providers, patients, and the church. AAs wanted provider counseling on the necessity of taking medicines and the consequences of not taking them, indicating the need for the AA community to support and teach self-advocacy in diabetes self-management, and the church to act as an advocate in ensuring medication use.
conclusionIntentional reasons of AAs with type 2 diabetes for not taking their medicines were related to their perception of medicines and illness. Solutions for enhancing diabetes medication adherence among AAs should focus on the roles of providers, patients, and the church.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.